Intercept Pharma falls again as article strikes cautious tone

|About: Intercept Pharmaceuticals (ICPT)|By:, SA News Editor

Intercept Pharmaceuticals (ICPT -22.3%) is trading sharply lower again today, and is now down some 43% from Friday's intraday high.

Perhaps helping to tip sentiment today is SA contributor Dr. Paul Nunzio DeSantis, whose article, while not necessarily bearish, strikes a cautious tone.

"Ultimately, OCA should receive FDA approval. However, my bearish tone stems from the likelihood that it will take significantly longer than investors currently anticipate and may not meet physician expectations of reversing or stopping fibrosis," DeSantis says.

Full article